miércoles, 17 de octubre de 2012

Information for Healthcare Professionals (Drugs) > Medication Guides

VIDEO ►
Information for Healthcare Professionals (Drugs) > Medication Guides

FDA Drug Info Rounds is a series of training videos for practicing clinical and community pharmacists. Drug Info Rounds is brought to you by pharmacists in the FDA's Center for Drug Evaluation and Research (CDER), Office of Communications (OCOMM), Division of Drug Information (DDI). Pharmacists in DDI answer hundreds of questions everyday about drug products and FDA actions. Our goal is to provide important and timely drug information to pharmacists so they can help patients make better medication decisions.

In this video, the FDA Drug Info Rounds pharmacists discuss Medication Guides. Questions have arisen concerning FDA's recommendations for providing a Medication Guide to a patient when the drug is dispensed to a health care professional who then administers the drug to the patient. In some cases, these drugs are administered to a patient several times a day or several times a week, further confusing healthcare professionals responsible for distributing Medication Guides.

In November of 2011, the FDA published a guidance document with helpful information about when and where to distribute Medication Guides. This guidance document includes a quick-reference table for possible scenarios. The guidance document along with a complete list of drugs that have Medication Guides is available on the following FDA Medication Guides website.
Drug Safety and Availability > Medication Guides

To watch the video please visit: Medication Guides ►

Medication Guides

Transcript¹

Questions have arisen concerning FDA's recommendations for providing a Medication Guide to a patient when the drug is dispensed to a health care professional who then administers the drug to the patient. In some cases, these drugs are administered to a patient several times a day or several times a week, further confusing healthcare professionals responsible for distributing Medication Guides.

In November of 2011, the FDA published a guidance document with helpful information about when and where to distribute Medication Guides. This guidance document includes a quick-reference table for possible scenarios. The guidance document along with a complete list of drugs that have Medication Guides is available on the following FDA Medication Guides² website.

Information for Healthcare Professionals (Drugs) > FDA Drug Info Rounds

FDA Drug Info Rounds

Welcome to Drug Info Rounds, a series of training videos for practicing clinical and community pharmacists. Drug Info Rounds is brought to you by pharmacists in the FDA’s Center for Drug Evaluation and Research (CDER), Office of Communications (OCOMM), Division of Drug Information (DDI). Pharmacists in DDI answer hundreds of questions everyday about drug products and FDA actions. Our goal is to provide important and timely drug information to pharmacists so they can help patients make better medication decisions.

Videos

Distribution of Medication Guides (October 2012)¹
FDA Drug Info Rounds pharmacists discuss the requirements for providing Medication Guides.
Medication Errors (September 2012) ²FDA Drug Info Rounds pharmacists discuss Medication Errors and how FDA educates the public about medication error prevention through public health advisories, medication guides and outreach partnerships with other organizations.
Patents and Exclusivity (August 2012)³FDA Drug Info Rounds pharmacists discuss Patents and Exclusivity and how they work in a similar fashion but are distinctly different from one another.
Accelerated Approval Program (July 2012)⁴
FDA Drug Info Rounds pharmacists discuss the Accelerated Approval Program and how FDA helps make new, potentially lifesaving drugs available more quickly.
Communicating Drug Safety Messages (April 20, 2011)⁵FDA Drug Info Rounds pharmacists discuss the vital role that pharmacists play in assisting the FDA with communicating drug safety messages.
Drug Shortages (December 1, 2010)⁶FDA Drug Info Rounds pharmacists discuss FDA's role in responding to and mitigating drug shortages.
Evamist (September 30, 2010)⁷
FDA Drug Info Rounds pharmacists discuss FDA's ongoing safety review of adverse event reports in children who may have been unintentionally exposed to the drug through skin contact with women using Evamist.
Proton Pump Inhibitors (PPIs) (August 9, 2010)⁸
FDA Drug Info Rounds pharmacists discuss new safety information about a possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors, strengths and limitations of the studies, and recommendations for pharmacists.
Long-Acting Beta-Agonists (LABAs) (July 16, 2010)⁹FDA Drug Info Rounds pharmacists discuss the new recommendations in the drug labels of Long-Acting Beta-Agonists (LABAs), and provide ways pharmacists can help patients use LABAs safely in the treatment of asthma.
Single-ingredient Oral Colchicine (May 14, 2010)¹⁰FDA Drug Info Rounds pharmacists discuss the differences between approved and unapproved colchicine products, concerns regarding unapproved single-ingredient oral colchicine, and how patients can offset the increased cost of Colcrys.